Professor David Price

Professor David Price
Professor David Price
Professor David Price

Chair of Primary Care Respiratory Med

About
Publications

Page 5 of 19 Results 201 to 250 of 923

  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Deniz, Y., Siddiqui, S., Rowe, P.
    AMCP Nexus 2022
    Contributions to Conferences: Abstracts
  • Clinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study

    Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
    CHEST 2022, pp. A28-A32
    Contributions to Journals: Abstracts
  • Clinical Review: The suggested management pathway for urticaria in primary care

    Ryan, D., Tanno, L. K., Angier, L., Clark, E., Price, D., Zuberbier, T., Maurer, M.
    Clinical and Translational Allergy, vol. 12, no. 10, e12195
    Contributions to Journals: Articles
  • Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study

    Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
    CHEST Annual Meeting, pp. A23-A27
    Contributions to Journals: Abstracts
  • Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort

    Price, D., Hancock, K., Doan, J., Taher, S. W., Muhwa, C. J., Farouk, H., Beekman, M. J.
    npj Primary Care Respiratory Medicine, vol. 32, 37
    Contributions to Journals: Articles
  • Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs

    Leving, M., van Boven, J. F., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Hartgers-Gubbels, E. S., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Kocks, J. W.
    International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2401-2415
    Contributions to Journals: Articles
  • Oral corticosteroids in asthma and beyond: moving forward

    Shi Kai Chan, J., Murray, R. B., Price, D.
    European Respiratory Journal, vol. 60, no. 3, 2200776
    Contributions to Journals: Editorials
  • Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy

    Chen, S., Miravitlles, M., Rhee, C. K., Pavord, I. D., Jones, R., Carter, V., Emmanuel, B., Alacqua, M., Price, D.
    International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2187—2200
    Contributions to Journals: Articles
  • Sociodemographic and clinical characteristics of patients with asthma who were prescribed ≥3 SABA canisters/year in the SABINA International study

    Al Zaabi, A., Mattarucco, W. J., Barriga, R. M., Wang, H., Diaz, D. V., Khattab, A., Pacheco Gallego, M., Farouk, H., Price, D.
    European Respiratory Society (ERS) International Congress., pp. 2374
    Contributions to Conferences: Abstracts
  • Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma

    Stanley, B., Menzies-Gow, A., Bourdin, A., Canonica, G. W., Gurnell, M., Reddel, H., Heaney, L. G., Carter, V., Chapaneri, J., Tran, T. N., Maslova, E., Price, D.
    European Respiratory Society (ERS) International Congress., 4420
    Contributions to Journals: Abstracts
  • Sociodemographic and clinical characteristics of patients with asthma who were prescribed ≥3 SABA canisters/year in the SABINA International study

    Alzaabi, A., Mattarucco, W. J., Barriga, R. M., Wang, H., Diaz, D., Khattab, A., Pacheco Gallego, M., Farouk, H., Price, D.
    European Respiratory Society (ERS) International Congress., 3397
    Contributions to Journals: Abstracts
  • Mortality Analyses on Systemic Corticosteroid Use: a Long-term Observational Study

    Xu, X., Tran, T. N., Golam, S., Carter, V., Price, D.
    BTS Winter Meeting 2021, pp. A7-A8
    Contributions to Journals: Abstracts
  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., JacobNara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    17th Annual Deutscher Allergiekongress (DAK) 2022, pp. 212
    Contributions to Journals: Abstracts
  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    Eastern Pulmonary Conference 2022
    Contributions to Conferences: Abstracts
  • A pragmatic primary practice approach to using specific IgE in allergy testing in asthma diagnosis, management, and referral

    Demoly, P., Liu, A. H., Rodriguez Del Rio, P., Pedersen, S., Casale, T. B., Price, D.
    Journal of Asthma and Allergy, vol. 2022, no. 15, pp. 1069—1080
    Contributions to Journals: Articles
  • Correspondence to Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

    Smith, P. K., Lesslar, O., Price, D. B.
    Allergy, vol. 77, no. 8, pp. 2571-2573
    Contributions to Journals: Letters
  • COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry

    Pace, W. D., Brandt, E., Carter, V. A., Chang, K., Edwards, C. L., Evans, A., Fox, C., Gaona, G., Han, M. K., Kaplan, A., Kent, R., Kocks, J. W. H., Kruszyk, M., Le Lievre, C. E., Li Voti, T., Mahle, C., Make, B., Ratigan, A. R., Shaikh, A., Skolnik, N., Stanley, B., Yawn, B. P., Price, D.
    Annals of Family Medicine, vol. 20, no. 4, pp. 319-327
    Contributions to Journals: Articles
  • Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma

    Stanley, B., Menzies-Gow, A., Bourdin, A., Canonica, G. W., Gurnell, M., Reddel, H. K., Heaney, L. G., Carter, V., Chapaner, J., Tran, T. N., Maslova, E., Maslova, E., Price, D.
    European Respiratory Society (ERS) International Congress.
    Contributions to Conferences: Abstracts
  • A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”

    Menzies-Gow, A., Hoyte, F. L., Price, D. B., Cohen, D., Barker, P., Kreindler, J., Jison, M., Brooks, C. L., Papeleu, P., Katial, R.
    Advances in Therapy, vol. 39, no. 8, pp. 3862-3865
    Contributions to Journals: Letters
  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    Aspen Allergy Conference – 40th Meeting
    Contributions to Conferences: Abstracts
  • Persistent OCS reduction regardless of starting OCS dose in patients with severe, OCS-dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study

    Cosio, B. G., Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    15º Congreso ALAT 2022
    Contributions to Conferences: Abstracts
  • Characterisation of the Australian adult population living with asthma: Severe exacerbation frequency, long-term OCS use and adverse effects.

    Hancock, K. L., Bosnic-Anticevich, S. Z., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Stewart, D., Thompson, P. J., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., Price, D.
    Pragmatic and Observational Research, vol. 2022, pp. 43-58
    Contributions to Journals: Articles
  • Healthcare resource utilisation associated with intermittent oral corticosteroid use in asthma

    Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Henley, W., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
    EAACI HYBRID CONGRESS 2022
    Contributions to Conferences: Abstracts
  • Biologics in severe asthma: the role of real-world evidence from registries

    Paoletti, G., Pepys, J., Casini, M., Di Bona, D., Heffler, E., Goh, C. Y., Price, D. B., Canonica, G. W.
    European Respiratory Review, vol. 31, no. 164, 210278
    Contributions to Journals: Articles
  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    2022 AANP National Conference
    Contributions to Conferences: Posters
  • Let’s improve COPD prognosis: a practical tool for primary care providers to identify the frequency and follow-up of COPD lung attacks

    Gerritsma, Y., Leving,, M., Dijk, L., van der Ham, I., Metz, B., Price, D., Salomé, P., Ställberg, B., Quint, J., Kocks, J.
    Dutch Lung Congress 2022
    Contributions to Conferences: Abstracts
  • Reply to: Cause or consequence?

    Bateman, E. D., Price, D., Wang, H., Schonffeldt, P., Catanzariti, A., van der Valk, R. J., Beekman, M. J.
    European Respiratory Journal, vol. 59, no. 6, 2200103
    Contributions to Journals: Comments and Debates
  • Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial

    Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongste, J. C., Pijnenburg, M. W., Thomas, M., Price, D.
    The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592
    Contributions to Journals: Articles
  • Reducción persistente de corticosteroides orales independientemente de la dosis basal, en pacientes con asma córtico-dependiente tratados con dupilumab: Estudio Liberty Asthma-Traverse

    Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    55 Congreso Separ, pp. 75
    Contributions to Journals: Abstracts
  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    The 35th annual
    Eastern Allergy Conference, pp. S9
    Contributions to Conferences: Abstracts
  • Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective

    Bhutani, M., Price, D., Winders, T. A., Worth, H., Gruffydd-Jones, K., Tal-Singer, R., Correia de Sousa, J., Dransfield, M. T., Peché, R., Stolz, D., Hurst, J. R.
    Advances in Therapy, vol. 39, pp. 2302–2322
    Contributions to Journals: Articles
  • Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT

    Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongeste, J., Pijnenburg, M. W., Thomas, M., Price, D.
    Efficacy and Mechanism Evaluation, vol. 9, no. 4
    Contributions to Journals: Articles
  • Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers

    W. H. Kocks, J., Wouters, H., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Dvortsin, E., Garcia Pardo, M., Gardev, A., Gawlik, R., van Geer - Postmus, I., van der Ham, I., Harbers, M., de la Hoz, A., Janse, Y., Kerkhof, M., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Leving, M. T.
    npj Primary Care Respiratory Medicine, vol. 32, no. 1, 18
    Contributions to Journals: Articles
  • Evaluation of critical inhalation technique errors in patients with COPD on Dry Powder Inhaler maintenance therapy based on their association with health status: findings from the PIFotal study.

    Kocks, J. W. H., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meije, J., Metz, B., Price, D., Rodríguez, M. R., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Voorham, J., Leving, M., Cvetkosvki, B.
    IPCRG 2022
    Contributions to Conferences: Abstracts
  • Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

    Bateman, E. D., Price, D., Wang, H., Khattab, A., Schonffeldt, P., Catanzariti, A., van der Valk, R. J., Beekman, M. J.
    European Respiratory Journal, vol. 59, no. 5
    Contributions to Journals: Articles
  • Suboptimal peak inspiratory flow and inhalation technique errors are associated with higher COPD-relateD healthcare costs: results from the PIFotal COPD study

    Leving, M., van Boven, J. F., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Cvetkosvki, B., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Hartgers-Gubbels, L., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Kocks, J. W.
    IPCRG 2022
    Contributions to Conferences: Abstracts
  • The burden of intermittent oral corticosteroid use in asthma

    Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
    IPCRG 2022
    Contributions to Conferences: Abstracts
  • Adverse Outcomes Post-initiation of Systemic Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: A Long-term Observational UK-based Study

    Price, D., Bafadhel, M., Papi, A., Carter, V., Tse, G., Ariti, C., Zhou, J., Skinner, D., Xu, X., Müllerová, H., Emmanuel, B.
    ATS 2022
    Contributions to Journals: Abstracts
  • Clinical Remission in Severe Asthma: A Pooled Post hoc Analysis of the Patient Journey with Benralizumab

    Menzies-Gow, A., Hoyte, F. L., Price, D., Cohen, D., Barker, P., Kreindler, J., Jison, M., Brooks, C. L., Papeleu, P., Katial, R.
    Advances in Therapy, vol. 39, no. 5, pp. 2065–2084
    Contributions to Journals: Articles
  • Impact of initiating biologics in patients with severe asthma and on long-term oral corticosteroids or rescue steroids (GLITTER)

    Chen, W., Tran, T. N., Sadatsafavi, M., Wong, N. C. B., Bulathsinhala, L., Gil, E. G., FitzGerald, J. M., Murray, R. B., Price, D., ISAR GLITTER Working Group
    ATS 2022, D102
    Contributions to Journals: Abstracts
  • Persistent Reductions in OCS Use in Patients with Severe, OCS-Dependent Asthma Treated with Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Ribas, C. D., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    ATS 2022, A2365
    Contributions to Journals: Abstracts
  • Predicting Pneumonia events in COPD patients using medical records

    Price, D., Henley, W., Carter, V., Skinner, D., Alexander, L., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
    ATS 2022
    Contributions to Journals: Abstracts
  • Prevalence of comorbidities in adults with severe asthma: results from the International Severe Asthma Registry (ISAR)

    Scelo, G., Porsbjerg, C. M., Carter, V., Ariti, C., Lyu, J., Eleangovan, N., Tran, T. N., Baker, P., Katial, R., Martin, N., Altraja, A., Rhee, C. K., FitzGerald, J. M., Hansen, S., Heaney, L. G., Hew, M., Siyue, M. K., Pfeffer, P. E., Puggioni, F., Tsai, M., von Bülow, A., Eileen, W., Price, D., ISAR PRISM Working Group
    ATS 2022
    Contributions to Journals: Abstracts
  • Prototype ORACLE Score Validation in NOVELTY: Predicted versus Observed Asthma Exacerbation Rates

    Couillard, S., Peterson, S., Bengtsson, T., van den Berge, M., Price, D., Beasley, R., Sadatsafavi, M., Janson, C., Belton, L., Fagerås, M., Müllerová, H., Pavord, I. D.
    ATS 2022, A486
    Contributions to Journals: Abstracts
  • Relationships Between Symptoms and Lung Function in Asthma and/or Chronic Obstructive Pulmonary Disease in the NOVELTY study

    Papi, A., Hughes, R., Olmo, R. d., Agusti, A., Chipps, B. E., Make, B., Tomaszewski, E., Peres Da Costa, K., Srivastava, D., Vestbo, J., Janson, C., Burgel, P., Price, D.
    ATS 2022, A4013
    Contributions to Journals: Abstracts
  • Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

    Porsbjerg, C. M., Menzies-Gow, A., Tran, T. N., Murray, R. B., Unni, B., Ang, S. L. A., Alacqua, M., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Belevskiy, A. S., Björnsdóttir, U. S., Bourdin, A., Busby, J., Walter Canonica, G., Christoff, G., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Hansen, S., Heaney, L. G., Heffler, E., Hew, M., Iwanaga, T., Jackson, D. J., Kocks, J. W. H., Kallieri, M., Bruce Ko, H., Siyue, M. K., Larenas-Linnemann, D., Lehtimäki, L. A., Loukides, S., Lugogo, N., Maspero, J. F., Papaioannou, A. I., Perez de Llano, L., Márcio Pitrez, P., Popov, T. A., Rasmussen, L. M., Rhee, C. K., Sadatsafavi, M., Schmidt, J., Siddiqui, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Upham, J. W., Eileen, W., Wechsler, M. E., Bulathsinhala, L., Carter, V., Chaudhry, I., Eleangovan, N., Hosseini, N., Rowlands, M., Price, D., van Boven, J. F.
    The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 5
    Contributions to Journals: Articles
  • Variation in demographic and clinical characteristics of Patients with COPD receiving care in U.S. primary care: data from the Advancing the Patient EXperience (APEX) in COPD registry

    Fox, C., Pace, W. D., Brandt, E., Chang, K., Edwards, C. L., Evans, A., Gaona, G., Han, M. K., Kaplan, A., Kent, R., Kocks, J. W., Kruszyk BEng, M., Le Lievre, C. E., Li Voti, T., Mahle, C., Make, B., Ratigan, A. R., Shaikh, A., Skolnik, N., Stanley, B., Yawn, B. P., Price, D.
    Pragmatic and Observational Research, vol. 2022, no. 13, pp. 17-31
    Contributions to Journals: Articles
  • Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)

    Cotton, S., Devereux, G., Abbas, H., Briggs, A. H., Campbell, K., Chaudhuri, R., Choudhury, G., Dawson, D., De Soyza, A., Fielding, S., Gompertz, S., Haughney, J., Lang, C. C., Lee, A., MacLennan, G., MacNee, W., McCormack, K., McMeekin, N., Mills, N. L., Morice, A., Norrie, J., Petrie, L., Price, D., Short, P., Vestbo, J., Walker, P., Wedzicha, J. A., Wilson, A., Lipworth, B. J.
    Trials, vol. 23, no. 1, 307
    Contributions to Journals: Articles
  • Asthma exacerbation and steroid burden in Australian primary care

    Price, D., Hancock, K. L., Bosnic-Anticevich, S., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Feldman-Stewart, D., Thompson, P., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., OPCA Improving Asthma outcomes in Australia Research Group
    The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 194
    Contributions to Journals: Abstracts
  • No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators

    Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
    TSANZSRS 2022, pp. 28-29
    Contributions to Journals: Abstracts
Show 10 | 25 | 50 | 100 results per page

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Contributions to Specialist Publications

Working Papers

Other Contributions